WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006087308) METHYLPHENYLCARBAMIC ACID 5-(4-ISOBUTYL-2,6,-DIOXOPIPERAZIN-l-YL) PYRIDINYL-2-YL ESTER ANS SALTS AS HORMONE SENSITIVE LIPASE INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/087308    International Application No.:    PCT/EP2006/050881
Publication Date: 24.08.2006 International Filing Date: 13.02.2006
IPC:
C07D 401/04 (2006.01), A61K 31/496 (2006.01)
Applicants: NOVO NORDISK A/S [DK/DK]; Novo Allé, DK-2880 Bagsværd (DK) (For All Designated States Except US).
DE JONG, Johannes Cornelis [NL/DK]; (DK) (For US Only).
JACOBSEN, Poul [DK/DK]; (DK) (For US Only)
Inventors: DE JONG, Johannes Cornelis; (DK).
JACOBSEN, Poul; (DK)
Common
Representative:
NOVO NORDISK A/S; Corporate Patents, Novo Allé, DK-2880 Bagsværd (DK)
Priority Data:
PA 2005 00221 15.02.2005 DK
PA 2005 00253 18.02.2005 DK
Title (EN) METHYLPHENYLCARBAMIC ACID 5-(4-ISOBUTYL-2,6,-DIOXOPIPERAZIN-l-YL) PYRIDINYL-2-YL ESTER ANS SALTS AS HORMONE SENSITIVE LIPASE INHIBITORS
(FR) ESTER ET SELS D'ACIDE METHYLPHENYLCARBAMIQUE 5-(4-ISOBUTYL-2,6,-DIOXOPIPERAZINE-L-YL) PYRIDINYLE-2-YL COMME INHIBITEURS DE LIPASE HORMONOSENSIBLE
Abstract: front page image
(EN)Novel methylphenylcarbamic acids, pharmaceutical compositions comprising them and use thereof in the treatment and/or prevention of diseases and disorders related to hormone sensitive lipase. More particularly, the compounds are useful for the treatment and/or prevention of diseases and disorders in which modulation of the activity of hormone sensitive lipase is beneficial.
(FR)L'invention concerne de nouveaux acides méthylphénylcarbamique, des compositions pharmaceutiques les renfermant et leur utilisation dans le traitement et/ou la prévention de maladies et de troubles associés à une lipase hormonosensible. Plus précisément, les composés sont utilisés dans le traitement et/ou la prévention de maladies et de troubles dans lesquels la modulation de l'activité d'une lipase hormonosensible est bénéfique.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)